Clinical trial
The Canadian Glaucoma Study
NCT00262626 · Dalhousie University, Other · Terminated
Key facts
| NCT number | NCT00262626 |
|---|---|
| Title | The Canadian Glaucoma Study |
| Official title | A Multicentre Study on the Risk Factors for the Progression of Open-Angle Glaucoma |
| Lead sponsor | Dalhousie University, Other |
| Collaborators | Canadian National Institute for the Blind Glaucoma Research Society of Canada Allergan Industry Merck Frosst Canada Ltd. Pfizer |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Glaucoma |
| Intervention type | Drug, Procedure |
| Interventions | Intraocular pressure reduction, Argon laser trabeculoplasty, Trabeculectomy |
| Enrollment | 430 |
| Start date | Feb 1, 1995 |
| Completion | Jun 1, 1995 |
| First posted | Dec 7, 2005 |
| Last update posted | Dec 7, 2005 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: